
viewLBT Innovations Limited
LBT Innovations raises capital and generates sales leads in the US
LBT Innovations Limited (ASX:LBT) chief executive officer Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology.
The ground-breaking medical technology company has also raised $5 million on the back of FDA clearance, which will enable the execution of commercialisation plans.
Barnes will attend this week's American Society of Microbiology Microbe meeting in San Francisco to further showcase the APAS Independence to the US and global markets.
Quick facts: LBT Innovations Limited
Price: 0.0955 AUD
ASX:LBT
Market: ASX
Market Cap: $27.61 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive

Emerald Clinics hits record number of patients; joins global fight...
Most read
Health
MGC Pharmaceuticals reports strong financial position as it drives medical...
2 days, 10 hours ago
Health
Emyria appoints global pharmaceutical expert to chair Strategic Advisory Board
6 days, 15 hours ago
Mining
Chalice Mining bolsters board with appointment of highly regarded former Rio...
6 days, 18 hours ago
Mining
Perseus Mining transitions to multi-mine, multi-jurisdictional gold producer...
4 days, 18 hours ago